UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
NIBEC claims stable growth despite loss in Q2
Nano Intelligence Biomedical Engineering Corp. (NIBEC) said Thursday that t...
by Lee Han-soo
|
2018-08-16 18:11
라인
Medipost sales increases but profits fall in 1H
Medipost said Thursday that it recorded 22.6 billion won ($20 million) in s...
by Lee Han-soo
|
2018-08-16 11:25
라인
Local patents increasingly target obesity
Amid forecasts that the obesity therapy market will rapidly grow, local res...
by Nam Doo-hyun
|
2018-08-14 16:26
라인
Korean pharmaceuticals enter biobank business
Korean pharmaceutical companies are jumping into the biobank business. Biob...
by Marian Chu
|
2018-08-14 12:07
라인
Who will be first to develop new acute pancreatitis remedy?
Korea’s Samsung Bioepis and Japan’s Takeda Pharmaceutical have teamed up to...
by Nam Doo-hyun
|
2018-08-14 10:32
라인
Samsung Bioepis to begin clinical trials for severe acute pancreatitis treatment
Samsung Bioepis said Monday that it plans to begin a phase 1 clinical study...
by Lee Han-soo
|
2018-08-13 11:25
라인
Celltrion to conduct clinical trials for its biosimilars
Celltrion said Friday that it has applied for the clinical trials for CT-P1...
by Lee Han-soo
|
2018-08-10 14:35
라인
Bio stock slump drags down diagnostics, equipment, reagent companies
The shares of diagnostics, equipment, reagent and clinical agent companies ...
by Nam Doo-hyun
|
2018-08-09 14:29
라인
FDA points out problems in Celltrion’s plant
The U.S. Food and Drug Administration (FDA) has issued an additional “Form ...
by Lee Han-soo
|
2018-08-08 14:42
라인
Beijing Northland mass produces Viromed’s NL003 for P3 clinical trial
Viromed said Tuesday that Beijing Northland Biotech, its Chinese partner, h...
by Lee Han-soo
|
2018-08-07 15:39
라인
‘CEO risk’ behind downfall of Nature Cell
Nature Cell CEO Ra Jeong-chan Nature Cell shares, which once went up to 6...
by Nam Doo-hyun
|
2018-08-06 14:33
라인
NIBEC completes pre-clinical trial for peptide-based osteoporosis treatment
Nano Intelligence Biomedical Engineering Corp. (NIBEC) said Thursday that i...
by Lee Han-soo
|
2018-08-03 16:07
라인
2018-listed pharmaceutical, medical shares tank
With pharmaceutical and medical device stocks tumbling in Seoul, share pric...
by Nam Doo-hyun
|
2018-07-31 14:02
라인
CHA University creates iPSC without immune rejection for half of Koreans
A research team from the Department of Biomedical Sciences at CHA Universit...
by Marian Chu
|
2018-07-26 17:00
라인
‘We know Korean genes best’
A Korean authority in genetic medicine established a genetic testing compan...
by Park Gi-taek
|
2018-07-24 14:42
라인
Theragen ETEX develops new method to treat recurrent pediatric brain tumors
Theragen ETEX said Tuesday that it has developed a technique, which can ide...
by Lee Han-soo
|
2018-07-19 15:42
라인
Medipost wins patent for Cartistem in Mexico
Medipost said Wednesday that it has acquired patents in Mexico on its core ...
by Lee Han-soo
|
2018-07-11 15:41
라인
Pharmicell reaffirms Cellgram-AMI’s therapeutic effect
Pharmicell said Monday that it has published a study result reconfirming th...
by Lee Han-soo
|
2018-07-10 10:38
라인
Will new patent help detect norovirus easily?
A new patent for checking antibody of norovirus is drawing attention, as th...
by Nam Doo-hyun
|
2018-07-05 17:24
라인
Medipost wins Japanese patent for fluids preventing hair loss
Medipost said Wednesday that it has acquired a patent in Japan on stem cell...
by Lee Han-soo
|
2018-07-05 11:09
-
이전
11
12
13
14
15
16
17
18
19
20
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top